Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 18, 2019 - Issue 8
Submit an article Journal homepage
227
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia

Ahmed Y AldryhimDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;Department of Pharmaceutics, College of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0001-7900-5389View further author information
ORCID Icon,
Abdulrahman AlomairDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;National pharmacovigilance Center, Saudi Food and Drug Authority, Riyadh, Saudi ArabiaView further author information
,
Meshari AlqhtaniDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Mansour A. MahmoudMedication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;Department of Clinical Pharmacy, College of Pharmacy, Taibah University, Medina, Saudi ArabiaView further author information
,
Thamir M AlshammariNational pharmacovigilance Center, Saudi Food and Drug Authority, Riyadh, Saudi Arabia;Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;College of Pharmacy, Hail University, Hail, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-5630-2468View further author information
ORCID Icon,
Lisa G PontGraduate School of Health, University of Technology Sydney, Broadway, AustraliaView further author information
,
Khalid M KamalDivision of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, Pittsburgh, PA, USAView further author information
,
Hisham AljadheyNational pharmacovigilance Center, Saudi Food and Drug Authority, Riyadh, Saudi Arabia;Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Alemayehu B MekonnenMedication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Monira AlwhaibiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Bander BalkhiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
&
Tariq M AlhawassiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence[email protected]
View further author information
 show all
Pages 745-752 | Received 20 Mar 2019, Accepted 12 Jun 2019, Published online: 11 Jul 2019

References

  • World Health Organization. Safety of Medicines. A guide to detecting and reporting adverse drug reactions. Geneva, Switzerland: World Health Organization; 2002. HO/EDM/QSM/2002.2.
  • Pirmohamed M, James S, Meakin S. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–19.
  • Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol. 2007;7:9.
  • Lazarou J, Pomeranz BH, Corey PN. The incidence of adverse drug reactions in hospitalized patients-a meta- analysis of prospective studies. JAMA. 1998;279:1200–1205.
  • Wester K, Jönsson AK, Spigset O, et al. Incidence of fatal adverse drug reactions: a population based study. Brit J Clin Pharmacol. 2008; 65(4):573–579.
  • Alhawassi TM, Krass I, Bajorek BV, et al. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079–2086.
  • Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017 Jun;73(6):759–770.
  • Shepherd G, Mohorn P, Yacoub K, et al. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother. 2012;46(2):169–175.
  • Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437–453.
  • Aljadhey H, Mahmoud MA, Mayet A, et al. Incidence of adverse drug events in an academic hospital: a prospective cohort study. Int J Qual Health Care. 2013 Dec;25(6):648–655.
  • Pirmohamed M, Breckenbridge AM. Adverse drug reactions. BMJ. 1998;316.
  • World Health Organization. The WHO programme for international drug monitoring. [ cited 2017 Sep 5]. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/National_PV_Centres_Map/en/
  • Alharf A, Alqahtani N, Saeed G, et al. Saudi Vigilance Program: challenges and lessons learned. Saudi Pharm J. 2018;26(3):388–395.
  • Alshammari TM, Alshakka M, Aljadhey H. Pharmacovigilance system in Saudi Arabia. Saudi Pharm J. 2017;25(3):299–305.
  • Aljadhey H, Mahmoud MA, Alshammari TM, et al. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia. Saudi Med J. 2015;36(9):1097–1102.
  • Alshammari TM, Al-Kathiri WH, Louet HL, et al. Completeness of adverse drug reactions reports of the Saudi adverse event reporting system. Saudi Med J. 2015;36(7):821–828.
  • Bawazir SA. Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting. Saudi Pharm J. 2006;14(1):75–83.
  • Khan TM. Community pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Saf. 2013;4(2):45–51.
  • Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14.
  • Adam M, Alswaida Y, Alshammari T. Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J. 2014;22(5):411–418.
  • Hadi MA, Helwani R, Long CM. Facilitators and barriers towards adverse drug reaction reporting: perspective of Malaysian hospital pharmacists. J Pharm Health Serv Res. 2013;4:155–158.
  • Liu J, Zhou Z, Yang S, et al. Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China. Int J Clin Pharm. 2015;37(3):457–464.
  • World Health Organization. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. Geneva, Switzerland: World Health Organization; 2001. WHO/EDM/TRM/2001.2.
  • Al-Arifi MN. Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia. Saudi Pharm J. 2013;21(4):351–360.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.